CN1989950A - Sterilizing effective antipruritic application agent - Google Patents
Sterilizing effective antipruritic application agent Download PDFInfo
- Publication number
- CN1989950A CN1989950A CN 200510133676 CN200510133676A CN1989950A CN 1989950 A CN1989950 A CN 1989950A CN 200510133676 CN200510133676 CN 200510133676 CN 200510133676 A CN200510133676 A CN 200510133676A CN 1989950 A CN1989950 A CN 1989950A
- Authority
- CN
- China
- Prior art keywords
- agent
- application agent
- sterilizing effective
- ethanol
- effective antipruritic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003795 chemical substances by application Substances 0.000 title claims abstract description 14
- 239000003908 antipruritic agent Substances 0.000 title claims abstract description 9
- 230000001954 sterilising effect Effects 0.000 title claims description 10
- 230000001139 anti-pruritic effect Effects 0.000 title claims description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 20
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 20
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 claims abstract description 14
- 239000005844 Thymol Substances 0.000 claims abstract description 7
- 229960000790 thymol Drugs 0.000 claims abstract description 7
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 claims description 6
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims description 6
- 229940041616 menthol Drugs 0.000 claims description 6
- 229960004756 ethanol Drugs 0.000 claims description 3
- 229960005150 glycerol Drugs 0.000 claims description 3
- 208000003251 Pruritus Diseases 0.000 abstract description 12
- 238000000034 method Methods 0.000 abstract description 3
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 abstract 1
- 239000003899 bactericide agent Substances 0.000 abstract 1
- 239000000470 constituent Substances 0.000 abstract 1
- 239000013078 crystal Substances 0.000 abstract 1
- 235000011187 glycerol Nutrition 0.000 abstract 1
- 229960004873 levomenthol Drugs 0.000 abstract 1
- 239000000047 product Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 4
- 230000002070 germicidal effect Effects 0.000 description 4
- 230000002045 lasting effect Effects 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 239000000645 desinfectant Substances 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 206010003399 Arthropod bite Diseases 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The invention relates to an antipruritic agent for treating skin pruritus, wherein the main constituents include thymol crystals, mentha camphor, glycerin, ethanol (75%) and highly effective bactericidal agent. The agent is prepared through specific processes.
Description
Technical field
The present invention belongs to a kind of external solvent that is used for the treatment of the local skin pruritus.
Background technology
Raising along with people's living standard, people are also more and more higher to the requirement of health care of body, because work, the influence of living environment, and heredity, endocrine disturbance's etc. cause, local skin pruritus disease is existed in a big chunk crowd, seriously disturb and affect people's operate as normal and life, because this reason, the product that has also occurred some treatment skin pruritus on the market, but the therapeutic effect of these products is not very lasting, and they all do not have significant sterilization efficacy, therefore, a kind of therapeutic effect is lasting, and the appearance with product of significant sterilization efficacy becomes a kind of needs in market.
Summary of the invention
It is very lasting that purpose of the present invention just provides a kind of local skin pruritus effect of not only treating, and the sterilizing effective antipruritic application agent with significant sterilization efficacy.
Purpose of the present invention realizes by such method: the composition of sterilizing effective antipruritic application agent mainly is made up of thymol, menthol, glycerol, ethanol (75%) and efficient germicide, is made just can obtain corresponding sterilizing effective antipruritic application agent through special technology by above-mentioned Main Ingredients and Appearance.
Advantage of the present invention and effect are: sterilizing effective antipruritic application agent, it is the preparation that is specifically designed to treatment local skin pruritus, the energy disinfectant antipruritic, protect from infection, mainly use for the itching skin disease patient, smear in the time of also can be for the local skin pruritus that causes because of mosquito bite, this agent is not only to the local skin pruritus persistent therapeutical effect that produces effect, and has the effect of killing newborn pathogenic bacteria.
The specific embodiment
Introduce the making prescription and the technology of product below
One, raw material
Thymol: the main medicament that is this agent; Menthol: the primary raw material that is this agent of system; Glycerol: in this agent, be used as and medicine and emollient; Ethanol (75%):, select pharmaceutical preparation for use as diluent and disinfectant; Efficient germicide.
Two, prescription (g)
Thymol 1; Menthol 3; Glycerol 5ML; Efficient germicide is an amount of; Ethanol (75%) adds to 100ML.
Three, preparation and using method
By formula ratio thymol, menthol are added the part dissolve with ethanol, add glycerol again after waiting to dissolve, and add remaining ethanol again, add efficient germicide at last, stir evenly finished product.Producing the expansion formula ratio in batches gets final product.
During use, dip in a little this agent with absorbent cotton, embrocate the place in skin pruritus, often use can be cured the pruritus disease; If pruritus is created in the exposed section,, generally embrocate this agent, second day flush away in night as face, hand etc.
Claims (1)
1, a kind of sterilizing effective antipruritic application agent, mainly be made up of thymol, menthol, glycerol, ethanol (75%) and sterilized dose: its principal character is: it mainly to form and part be made up of thymol, menthol, glycerol, ethanol (75%), and contain sterilized dose.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200510133676 CN1989950A (en) | 2005-12-26 | 2005-12-26 | Sterilizing effective antipruritic application agent |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200510133676 CN1989950A (en) | 2005-12-26 | 2005-12-26 | Sterilizing effective antipruritic application agent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1989950A true CN1989950A (en) | 2007-07-04 |
Family
ID=38212635
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200510133676 Pending CN1989950A (en) | 2005-12-26 | 2005-12-26 | Sterilizing effective antipruritic application agent |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1989950A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101732289B (en) * | 2008-11-25 | 2011-12-21 | 天津市畜牧兽医研究所 | External tincture for treating rabbit sarcoptidosis |
| CN103637920A (en) * | 2013-12-10 | 2014-03-19 | 彭再辉 | Repellent floral water for children for eliminating heat rash and relieving itching |
-
2005
- 2005-12-26 CN CN 200510133676 patent/CN1989950A/en active Pending
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101732289B (en) * | 2008-11-25 | 2011-12-21 | 天津市畜牧兽医研究所 | External tincture for treating rabbit sarcoptidosis |
| CN103637920A (en) * | 2013-12-10 | 2014-03-19 | 彭再辉 | Repellent floral water for children for eliminating heat rash and relieving itching |
| CN103637920B (en) * | 2013-12-10 | 2016-01-13 | 彭再辉 | A kind of child dispels the antipruritic mosquito-repellent perfume of miliaria |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9125964B2 (en) | Pharmaceutical composition and device for preventing, treating and curing ulcers on a diabetic foot and other wounds, which includes snail slime from the species Cryptophalus aspersus or Helix aspersa muller and pharmaceutically acceptable carriers and/or additives | |
| JP2011522831A (en) | Acne treatment composition containing nanosilver and use thereof | |
| JP2019517533A (en) | External pharmaceutical composition for treatment of various wound wounds of skin and preparation method thereof | |
| CN105848660A (en) | Anti-inflammatory solution comprising sodium hypochlorite | |
| CN101843637B (en) | External spray for preventing and treating beriberi and preparation method | |
| JP5578880B2 (en) | Anti-malassezia agent | |
| JP2011173837A5 (en) | ||
| CN107519236A (en) | A kind of topical agent for treating onychomycosis | |
| Scotti et al. | Anti-inflammatory and wound healing effects of an essential oils-based bioadhesive gel after oral mucosa biopsies: preliminary results | |
| DE69801820T2 (en) | Use of dichlorobenzyl alcohol to make a composition for topical treatment of inflammation | |
| US20060105057A1 (en) | Compositions using tetrasilver tetroxide and methods for management of skin conditions using same | |
| CN1989950A (en) | Sterilizing effective antipruritic application agent | |
| WO2015159206A1 (en) | Copper alloy microparticles for use in the treatment of an external skin lesion | |
| CN109498599A (en) | Daily health caring sustained-release gel ointment table | |
| Sonekar et al. | Clinical evaluation of panchavalkal kashay dhavan In the management of diabetic wound | |
| CN102008586A (en) | Effective drug for treating skin disease | |
| US20040022868A1 (en) | Compositions using tetrasilver tetroxide and methods for management of skin conditions using same | |
| CN106466309A (en) | A kind of radiation-induced skin ulcer nursing emulsifiable paste and preparation method thereof | |
| CN101375837B (en) | Medicament composition for treating dermatopathy as well as preparation method and use thereof | |
| KR20210031466A (en) | Enhancement of antibacterial activity of depsipeptide antibiotics using synergistic boric acid | |
| Boddu et al. | Excipients and non-medicinal agents as active pharmaceutical ingredients | |
| CN102210812B (en) | Compound Retapamulin medicinal membrane agent and preparation method thereof | |
| CN109045029A (en) | A kind of purposes of imidazopyridine derivatives | |
| CN1268349C (en) | Water soluble medicament for anti inflammation, repressing bacteria, eliminating pes off smell and treating asjike, and its application | |
| CN1082372C (en) | Liquid medicine for treatment of bromidrosis, and its preparing method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |